Pricing Log in Create free account

BRIACELL THERAP (BCTX) vs Edesa Biotech, Inc. (EDSA)

BRIACELL THERAP and Edesa Biotech, Inc. are both Biotechnology companies. BRIACELL THERAP and Edesa Biotech, Inc. are of similar size ($28.8M and $28.6M). Across the 8 metrics below, BRIACELL THERAP leads on 5 and Edesa Biotech, Inc. on 3.

Valuation

Metric BCTX EDSA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 59.44 9.40
P/B 1.29 48.99 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.01 n/m 0.66
EV/Sales n/m 28.02 9.02
Earnings yield (174.34%) (77.88%) (32.88%)
Free cash flow yield (145.86%) (45.60%) (23.13%)

Profitability

Metric BCTX EDSA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (212.23%) (531.32%) (51.96%)
Return on assets (154.34%) (102.46%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCTX EDSA Biotechnology median
Revenue growth (TTM) — (43.48%) 6.76%
EPS growth (last fiscal year) 88.66% 34.20% 29.88%
Revenue growth, 5-year CAGR — (15.40%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX EDSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 2.76 4.97
Net debt to EBITDA 0.57 1.39 1.01

Dividend

Metric BCTX EDSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCTX EDSA Biotechnology median
Market cap 28.55m 28.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack